XERIS PHARMACEUTICALS INC Restructuring Charges
XERIS PHARMACEUTICALS INC reported Restructuring Charges of $275.00 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2021-08-05
- XERIS PHARMACEUTICALS INC restructuring charges for the quarter ending 2021-06-30 was -$35.00K.
- XERIS PHARMACEUTICALS INC restructuring charges for the quarter ending 2021-03-31 was $310.00K.
- XERIS PHARMACEUTICALS INC restructuring charges for the quarter ending 2020-09-30 was $778.00K.
- XERIS PHARMACEUTICALS INC restructuring charges for fiscal 2020 was $1.66M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 12 month |
|---|---|---|---|
| 2021-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $275.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $310.00K 10-Q · filed 2021-05-13 | ||
| 2020-12-31 | $1.66M 10-K · filed 2021-03-09 | ||
| 2020-09-30 | $778.00K 10-Q · filed 2020-11-09 |